Outcome of patients activating an unrelated donor search for severe acquired aplastic anemia
Open Access
- 27 June 2013
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 88 (10) , 868-873
Abstract
Patients with severe aplastic anemia (SAA) without a sibling donor receive immunosuppressive treatment (IST) with anti‐thymocyte globulin (ATG). In the case of no response to IST, a voluntary unrelated donor (VUD) search is usually started. This study analyzes the outcome of ATG‐refractory SAA patients activating a VUD search. Of 179 patients, 68 had at least one HLA‐A, –B, and –DR matched donor identified and underwent HSCT while 50 also with a donor were not transplanted because of early death (8), late response to IST (34), transplant refusal (1), or other (7). Conversely, 61 had no matched donor, 13 of those ultimately received a mismatched HSCT. All but one received marrow stem cells. Among patients aged P = 0.01). There was also a survival advantage independent of recipient age when the donor search was initiated in the recent 2000–2005 study‐period (74% ± 6% versus 47% ± 10%, P < 0.05). In multivariate analysis, the identification of a matched VUD tended to impact favourably on survival in patients with a recent donor search (P = 0.07). This study provides evidence for the use of unrelated donor HSCT in children and adults with IST‐refractory SAA. Am. J. Hematol. 88:868–873, 2013. © 2013 The Authors. American Journal of Hematology published by Wiley Periodicals, Inc.Keywords
This publication has 30 references indexed in Scilit:
- Aplastic Anemia: Pathophysiology and TreatmentTransplantation and Cellular Therapy, 2010
- Unrelated stem cell transplantation for severe acquired aplastic anemia: improved outcome in the era of high-resolution HLA matching between donor and recipientHaematologica, 2007
- Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapyBlood, 2006
- Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemiaBone Marrow Transplantation, 2006
- Guidelines for the diagnosis and management of acquired aplastic anaemiaBritish Journal of Haematology, 2003
- Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor ProgramBlood, 2002
- Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemiaBlood, 2000
- Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patientsBlood, 2000
- Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemiaSeminars in Hematology, 2000
- Treatment of Aplastic Anemia with Antilymphocyte Globulin and Methylprednisolone with or without CyclosporineNew England Journal of Medicine, 1991